Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

Scientists are laying the groundwork for treating one of the most common genetic conditions in humans. Research out today ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for ...

The ACC has published a scientific statement regarding the use of gene editing therapy for cardiovascular disease.

Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...

CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...